Catagory 1: Allergies
- Typical dose: 5 ml.
- Typical admiinistrations per day: 2
- Typical interval to initial response 1 - 3 days.
- Typical interval to benefit plateau: 3 - 7 days.
- Typical response code: 2 - 3. No reduction or elimination of other therapeutics until justified by patient's condition.
|
Catagory 2: Arthritis
- Typical dose: 5 ml.
- Typical admiinistrations per day: 2
- Typical interval to initial response 7 - 21 days.
- Typical interval to benefit plateau: 42 - 56 days.
- Typical response code: 2 - 3. No reduction or elimination of other therapeutics until justified by patient's condition.
|
Catagory 3: Benign Prostatic Hyperplasia
- Typical dose: 5 ml.
- Typical admiinistrations per day: 2
- Typical interval to initial response 7 - 14 days.
- Typical interval to benefit plateau: 14 - 28 days.
- Typical response code: 2 - 3. No reduction or elimination of other therapeutics until justified by patient's condition.
|
Catagory 4: Cancer (adjunctive use only)
- Typical dose: 5 ml.
- Typical administrations per day: 2.
- Typical interval to initial response: 7 - 14 days.
- Typical interval to benefit plateau: not available.
- Typical response code: Noticeable improvement in overall condition. No modification to treatment protocol.
|
Catagory 5: Celiac Sprue
- Typical dose: 5 ml.
- Typical administrations per day: 2.
- Typical interval to initial response: 5 days.
- Typical interval to benefit plateau: 5 days.
- Typical response code: 2 - 4. No relaxation of dietary restrictions should be made before day 4. Normalization of diet should not become permanent unless blood tests return negative for all antigens.
|
Catagory 6: Crohn's Disease
- Typical dose: 5 ml.
- Typical administrations per day: 2.
- Typical interval to initial response: 7 - 14 days.
- Typical interval to benefit plateau: 42 - 56 days.
- Typical response code: 2 -4. No reduction or elimination of other therapeutics until justified by patient's condition.
|
Catagory 7: Diabetes Type II
- Typical dose: 5 ml.
- Typical administrations per day: 2.
- Typical interval to initial response: 1 - 7 days.
- Typical interval to benefit plateau: 14 - 28 days.
- Typical response code: 2 - 3. No reduction or elimination of other therapeutics until justified by patient's condition
|
Catagory 8: Hypertension
- Typical dose: 5 ml.
- Typical administrations per day: 2.
- Typical interval to initial response: 7 days.
- Typical interval to benefit plateau: 28 - 56 days.
- Typical response code: 2 - 3. No reduction or elimination of other therapeutics until justified by patient's condition
|
Catagory 9: Lupus (discoid & systemic)
- Typical dose: 5 ml.
- Typical administrations per day: 2.
- Typical interval to initial response: 7 - 14 days.
- Typical interval to benefit plateau: 28 - 58 days.
- Typical response code: 2 -3. No reduction or elimination of other therapeutics until justified by patient's condition.
|
Catagory 10: Multiple Sclerosis
- Typical dose: 5 ml.
- Typical administrations per day: 2.
- Typical interval to initial response: 7 - 28 days.
- Typical interval to benefit plateau: 28 - 180 days.
- Typical response code: 2 - 3. No reduction or elimination of other therapeutics until justified by patient's condition.
|
Catagory 11: Perthes Disease (active)
- Typical dose: 5 ml.
- Typical administrations per day: 2.
- Typical interval to initial response: 1 - 2 days.
- Typical interval to benefit plateau: 7 - 28 days.
- Typical response code: 3 - 4. No reduction or elimination of other therapeutics until justified by patient's condition.
|
Catagory 12: Premenstrual Syndrome & Endometriosis
- Typical dose: 5 ml.
- Typical administrations per day: 2.
- Typical interval to initial response: 1 - 2 days.
- Typical interval to benefit plateau: 14 days.
- Typical response code: 2 - 4. Use of Cytolog may be limited to post ovulation period.
|
Catagory 13: Prion Diseases (Kuru & Creutzfeld-Jakob Syndrome)
- Typical dose: 5 ml.
- Typical administrations per day: 2.
- Typical interval to initial response: 12 - 28 days.
- Typical interval to benefit plateau: 28 - 56 days.
- Typical response code: 2 - 3. No reduction or elimination of other therapeutics until justified by patient's condition
|
Catagory 14: Psoriasis
- Typical dose: 5 ml.
- Typical administrations per day: 2.
- Typical interval to initial response: 3 - 7 days.
- Typical interval to benefit plateau: 14 -28 days.
- Typical response code: 2 - 3. No reduction or elimination of other therapeutics until justified by patient's condition.
|
Catagory 15: Sjogren's Syndrome
- Typical dose: 5 ml.
- Typical administrations per day: 2.
- Typical interval to initial response: 7 - 14 days.
- Typical interval to benefit plateau: 14 - 28 days.
- Typical response code: 3 - 4. No reduction or elimination of other therapeutics until justified by patient's condition.
|
Catagory 16: Spinal Muscular Atrophy
- Typical dose: 5 ml.
- Typical administrations per day: 2.
- Typical interval to initial response: 7 - 14 days.
- Typical interval to benefit plateau: 180 days.
- Typical response code: 1 - 2. Increased consumption of water should be encouraged in adult patients
|
Catagory 17: Thrombocytopenia (ideopathic & autoimmune)
- Typical administrations per day: 2
- Typical interval to initial response: 1 - 2 days
- Typical interval to benefit plateau: 4 - 10 days
- Typical response code: 3 - 4. No reduction or elimination of other therapeutics until justified by patient's condition
|
Catagory 18: Topical applications (burns, infections, insect bites, diaper rash & herpetic lesions)
- Typical method of administration: Spray or apply with a sterile pad to affected area.
- Typical administrations per day: 3 - 5 as needed.
- Typical interval to initial response: 4 - 24 hours.
- Typical interval to benefit plateau: Variable with condition.
- Typical response code: 3 - 4. Typical observations include accelerated healing and reduced tendency to scar.
|
Catagory 19: Acute Viral Infections
- Typical dose: 5 - 10 ml.
- Typical administrations per day: 2 - 3.
- Typical interval to initial response: 4 - 24 hours.
- Typical interval to benefit plateau: 2 - 7 days.
- Typical response code: 3 - 4. No reduction or elimination of other therapeutics until justified by patient's condition.
|
Catagory 20: Chronic Viral Infections
- Typical dose: 2.5 - 5 ml.
- Typical administrations per day: 3 - 4.
- Typical interval to initial response: 7 - 14 days.
- Typical interval to benefit plateau: 28 - 90 days.
- Typical response code: 2 - 4.
|